"Statin Discontinuation Common In High-Risk Patients" - Darlene Dobkowski
A perceived lack of need is a major reason why patients with elevated CVD risk discontinue statin therapy, according to data presented at the American College of Cardiology Scientific Session. In a new study, most high-risk patients who discontinued statins refused to resume therapy, according to the researchers. “It’s important to discuss with your patient at the time that you start a statin or adjust the dose of the statin that if you perceive that you’re having side effects, you call to discuss those side effects,” said Robert Rosenson, MD, professor of medicine and cardiology, and director of Cardiometabolic disorders at the Icahn School of Medicine at Mount Sinai. “Many people do not have a true statin muscle complaint. Many of them have arthritis and they worsen with the change in weather, and many people are influenced by what they read on the internet or hear in the news.”
- Robert Rosenson, MD, Professor, Medicine, Cardiology, Director, Cardiometabolic Disorders, Icahn School of Medicine at Mount Sinai
